The secretion of prolactin (PRL) from pituitary lactotrophs of the rat is predominantly under inhibitory control exerted by dopamine (DA) of hypothalamic origin (1). Other PRL-inhibiting substances of hypothalamic origin include somatostatin and endothelin (ET) (2). The latter is the focus of a recent article from the Stojilkovic lab (3) and of this report. In addition to the PRL-inhibiting substances, a host of candidate PRL-releasing hormones, also of hypothalamic origin, exist (2). These include thyrotropin-releasing hormone (TRH), vasoactive intestinal polypeptide, angiotensin II, oxytocin (OT), and even DA itself (2). Each has well-described receptors on the lactotroph membrane and, in most cases, has well-defined postreceptor transduction cascades that regulate PRL secretion. These include the activation of excitatory or inhibitory guanosine triphosphate (GTP)-binding proteins (G proteins) (G s , G q , and G i/o ), which activate or inhibit adenylyl cyclase with downstream effects on adenosine 3′,5′-monophosphate (cAMP) formation or which activate phospholipase C (PLC). Although the nature of these pathways differs, they share one final common denominator: They each regulate PRL secretion by affecting the intracellular levels of calcium, the key ion evoking PRL exocytosis.
DA, the initial ET-mediated stimulatory response is followed by a sustained inhibition of PRL secretion, which lasts for tens of minutes after the removal of the ET-1 (19) . The effect of ET-1 in lactotrophs is partially mediated by the activation of large-conductance Ca 2+ -activated K + channels (BK Ca ). In the presence of DA, the effect of ET-1 on BK Ca channels is reversed from stimulatory to inhibitory (20) . The presence of particular G proteins and their postreceptor coupling to ET A receptors may determine whether lactotrophs respond to ETs by increasing or decreasing intracellular Ca and thus excite or inhibit PRL secretion.
The biphasic PRL response to ET-1 is accompanied by a biphasic response in the intracellular Ca 2+ concentration ([Ca 2+ ] i ), suggesting that the PRL response is due, at least in part, to the Ca 2+ response (21) . This response can be mathematically modeled as illustrated in Fig. 1, A and B. The biphasic pattern of changes in Ca 2+ concentration and PRL secretion in response to ET-1 reported by the Stojilkovic lab (an initial increase followed by a reduction to below baseline levels) was unusual and seemed to mimic the combined actions of TRH (the initial rise) (22) and DA (the sustained inhibition) (1). The initial transient increase in [Ca 2+ ] i was not due to Ca 2+ influx, because it was not affected by the Ca 2+ -channel blocker nifedipine. Thus, the initial [Ca 2+ ] i spike was due to the release of Ca 2+ from intracellular stores (21) , whereas the later sustained reduction in [Ca 2+ ] i was due to membrane hyperpolarization, which deactivates Ca 2+ channels (21) . Thus, ET-1 appeared to have at least two distinct effects on lactotrophs: one stimulatory and one inhibitory.
Following this work, the Stojilkovic lab focused on the signaling pathways mediating the effects of ET-1 in lactotrophs. ET-1 inhibited Ca 2+ influx through a pertussis toxin (PTX)-sensitive G i/o signaling pathway by activating inward rectifying K + (GIRK) channels, hyperpolarizing the cell (23) . The initial rise in [Ca 2+ ] i was mediated by a G protein other than G i/o . The most recent data demonstrate that four different G protein pathways (Fig. 2) mediate the effects of ET-1 in lactotrophs (3) . The initial increase in [Ca 2+ ] i after the application of nanomolar concentrations of ET-1, and the initial increase in PRL secretion, are mediated by a G q pathway. This pathway has been well characterized: The G q α subunit of the activated G protein activates PLC, catalyzing the hydrolysis of phosphatidylinositol 4,5-bisphosphate to inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol. The IP 3 binds to receptors in the endoplasmic reticulum (ER) membrane, opening the channels and allowing Ca 2+ to flow down its concentration gradient from the ER into the cytosol (Fig. 1 , A and C) (24) . The resulting spike in [Ca 2+ ] i produces a spike in PRL secretion (Fig. 1B) .
The second pathway activated by ET-1 is mediated by the heterodimer G i/o βγ. This signaling molecule acts directly on ion channels, inactivating Ca 2+ channels (25, 26) and activating GIRK channels (27) . Although there was no evidence for ET-1-mediated Ca 2+ channel inhibition in lactotrophs, ET-1 activated GIRK channels (3, 23) . Activation of these channels by G i/o βγ leads to membrane hyperpolarization (Fig. 1D) (Fig. 1, A and B) . The third and fourth pathways of action of ET-1 are mediated by G proteins of the type G z , a subfamily of G i that is resistant to PTX (28, 29) . Both the G z α and G z βγ arms of the activated G z protein play important roles in the response to nanomolar concentrations of ET-1 (3). Like G i α, G z α inhibits adenylyl cyclase, thus reducing cellular cAMP levels (30) . Andric et al. show that the application of ET-1 leads to a reduction in cAMP concentration in lactotrophs (Fig. 1E ) and that this effect is resistant to PTX (3). The reduction in cAMP results in a decline in the activity of protein kinase A (PKA), a kinase with many potential targets, including the priming of vesicles for exocytosis (31) . Thus, the finding of Andric et al. that PRL secretion declines when cAMP levels are reduced is consistent with what one would expect from a reduction in PKA activity. This inhibitory effect on secretion is downstream of Ca 2+ entry, because ET-1 inhibits PRL secretion even when the Ca 2+ levels are elevated (3). Also, when cAMP was elevated with forskolin (short-circuiting the effect of G z α), the inhibitory action of ET-1 on PRL secretion was not sustained but was rapidly terminated after the removal of ET-1 from the bath. This suggests that the pathway mediated by G z α is responsible for the PRL inhibition that remains after the removal of ET-1 (Fig. 1B) .
Andric et al. unmask the fourth pathway of ET-1 action by using picomolar concentrations of ET-1. These low concentrations have no effect on [Ca 2+ ] i (Fig. 3A) but nearly eliminate PRL secretion (Fig. 3B) , even in the presence of PTX (3). PRL secretion is also reduced at picomolar concentrations of ET-1 when cAMP is elevated by forskolin. Together, these data suggest that the fourth pathway is downstream of Ca 2+ entry, is PTX-resistant, and does not operate through inhibition of adenylyl cyclase. This leads Andric et al. to conclude that G z βγ is mediating the response and that it is directly inhibiting the exocytotic machinery. It has recently been demonstrated that G protein βγ dimers can directly inhibit secretion by binding to soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complexes (32, 33) , which are key components of the vesicle fusion machinery. Gβγ competes with the Ca 2+ sensor synaptotagmin for binding to SNARE complexes, thus reducing Ca 2+ -evoked exocytosis (32) . This could very well be the mechanism for the fourth ET-1 inhibitory pathway in lactotrophs. Andric et al. show that this inhibitory action is terminated quickly after removal of the agonist ET-1, because PRL secretion returns to basal levels rapidly in the presence of forskolin (that is, when the G z α pathway is short-circuited). Thus, the G z βγ pathway contributes to the inhibition of PRL secretion only while ET-1 is present (Fig. 1B) .
The work of the Stojilkovic lab and others clearly demonstrates the capacity of G protein-coupled receptors to initiate a wide array of actions, some stimulatory and some inhibitory. What is the physiological purpose of the initial stimulatory action? To what extent are the inhibitory actions redundant? It seems unnecessary to hyperpolarize the lactotroph and directly inhibit secretion. Then again, hormones such as TRH or OT may act in concert with ET in physiological settings, and these hormones stimulate lactotroph activity, so perhaps it is wise to be doubly sure by inhibiting several targets. Also, Ca 2+ has several physiological roles in addition to its role in exocytosis, such as the regulation of gene expression (34) and enzyme activation (35) . So the many targets of the ET A receptor may serve many physiological purposes. 
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